A 6-month, Double-blind, Randomised, Multicenter, Multinational Trial to Investigate the Effect of 500 µg Roflumilast Tablets Once Daily Versus Placebo on Pulmonary Function in Patients With COPD. The ACROSS Trial

Name: A 6-month, Double-blind, Randomised, Multicenter, Multinational Trial to Investigate the Effect of 500 µg Roflumilast Tablets Once Daily Versus Placebo on Pulmonary Function in Patients With COPD. The ACROSS Trial
Creator: Vivli
Published: 2024-12-04 16:00:04
License: 暂无描述

DataCite Commons2024-12-04 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00008189/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

The aim of this trial is to determine the efficacy, safety and tolerability of 500 µg Roflumilast tablets once daily in patients with COPD in China, Hong Kong, and Singapore.

提供机构：

Vivli

创建时间：

2022-07-06